Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment

The human papillomavirus (HPV) 9-valent, recombinant vaccine (Gardasil™9) helps protect young adults (males and females) against anogenital cancers and genital warts caused by certain HPV genotypes (ref. Gardasil™9 insert). This vaccine is administered intramuscularly (IM). The aim of this study was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine X
Hauptverfasser: Meyer, Brian K., Kendall, Mark A.F., Williams, Donna M., Bett, Andrew J., Dubey, Sheri, Gentzel, Renee C., Casimiro, Danilo, Forster, Angus, Corbett, Holly, Crichton, Michael, Baker, S. Ben, Evans, Robert K., Bhambhani, Akhilesh
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2019
Schlagworte:
Regular paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668242/
https://ncbi.nlm.nih.gov/pubmed/31384745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100030
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge